-
12481por Bifano, Marc, Adamczyk, Robert, Hwang, Carey, Kandoussi, Hamza, Marion, Alan, Bertz, Richard J.“…BACKGROUND AND OBJECTIVE: Chronic hepatitis C virus (HCV) infection is a major cause of liver transplantation. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12482por Hunt, Kelsey, Mondal, Prosanta, Konrad, Stephanie, Skinner, Stuart, Gartner, Kali, Lim, Hyun J“…Two hundred eighteen (53%) were male, mean (± SD) age was 35.6 ±10.1 years, 257 (70.8%) were First Nations or Métis, 312 (80.2%) were hepatitis C virus (HCV) coinfected and 300 (73.3%) had a history of injection drug use (IDU). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12483por Sepanlou, Sadaf Ghajarieh, Malekzadeh, Fatemeh, Naghavi, Mohsen, Forouzanfar, Mohammad Hossein, Shahraz, Saeid, Moradi-Lakeh, Maziar, Malekzadeh, Reza, Poustchi, Hossein“…Total numbers of DALYs and deaths due to acute hepatitis C, stomach cancer, and liver cancers are rising. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12484por Ouwerkerk-Mahadevan, Sivi, Beumont-Mauviel, Maria, Mortier, Steven, Peeters, Monika, Verloes, Rene, Truyers, Carla, Mannens, Geert, Wynant, Inneke, Simion, Alexandru“…BACKGROUND: Simeprevir is a N3/4 protease inhibitor approved for the treatment of hepatitis C virus (HCV) infection. HCV prevalence is higher in patients with chronic kidney disease compared with the general population; safe and efficacious therapies in renal impairment are needed. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12485por NIE, BIN, ZHANG, GUANGJIONG, GUO, YONGCAN, LI, QINGFENG, LIU, JINBO, TU, ZHIGUANG“…The classification of hepatitis C virus (HCV) genotypes is of clinical importance as it may help to predict drug therapy responses and estimate treatment duration. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12486por Sagir, Abdurrahman, Glaubach, Birgit, Sahin, Kurtulus, Graf, Dirk, Erhardt, Andreas, Oette, Mark, Häussinger, Dieter“…To observe the hepatotoxicity of HAART, patients with chronic viral hepatitis B or C were excluded by detection of hepatitis B surface antigens and hepatitis C virus antibodies. Patients with chronic alcohol intake were excluded by measuring carbohydrate-deficient transferrin (CDT). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12487por Schreiber-Dietrich, Dagmar, Pohl, Margret, Cui, Xin-Wu, Braden, Barbara, Dietrich, Christoph F., Chiorean, Liliana“…SUBJECT AND METHODS: In 49 patients with chronic viral hepatitis (38 with chronic hepatitis B, 11 with chronic hepatitis C, 31 male, 18 female; age range 1 to 17 years), and in 51 healthy controls (25 male, 26 female; age range 4 to 16 years), the total perihepatic lymph node volume was assessed using transabdominal ultrasonography as previously described in adult patients. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12488“…Microscopic vascular invasion, positivity for hepatitis B surface antigen or antibody to hepatitis C, and an indocyanine green retention test at 15 minutes of more than 10% were found to be significantly correlated with disease-free overall survival. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12489por Manolakopoulos, Spilios, Kranidioti, Hariklia, Goulis, John, Vlachogiannakos, John, Elefsiniotis, John, Kouroumalis, Elias A., Koskinas, John, Kontos, George, Evangelidou, Eftychia, Doumba, Polyxeni, Sinakos, Emmanuel, Vafiadou, Ιrini, Koulentaki, Mairi, Papatheodoridis, George, Akriviadis, Evangelos“…BACKGROUND: The aim of our study was to evaluate the safety and efficacy of triple therapy using boceprevir (BOC) with pegylated interferon (pIFN)/ribavirin (RBV) in chronic hepatitis C (CHC) genotype 1 (G1) treatment-experienced patients with advanced fibrosis or compensated cirrhosis. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12490por Greninger, Alexander L., Naccache, Samia N., Federman, Scot, Yu, Guixia, Mbala, Placide, Bres, Vanessa, Stryke, Doug, Bouquet, Jerome, Somasekar, Sneha, Linnen, Jeffrey M., Dodd, Roger, Mulembakani, Prime, Schneider, Bradley S., Muyembe-Tamfum, Jean-Jacques, Stramer, Susan L., Chiu, Charles Y.“…We report unbiased metagenomic detection of chikungunya virus (CHIKV), Ebola virus (EBOV), and hepatitis C virus (HCV) from four human blood samples by MinION nanopore sequencing coupled to a newly developed, web-based pipeline for real-time bioinformatics analysis on a computational server or laptop (MetaPORE). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12491por Kapoor, Amit, Kumar, Arvind, Simmonds, Peter, Bhuva, Nishit, Singh Chauhan, Lokendra, Lee, Bohyun, Sall, Amadou Alpha, Jin, Zhezhen, Morse, Stephen S., Shaz, Beth, Burbelo, Peter D., Lipkin, W. Ian“…Using this approach, we detected and genetically characterized a novel human virus, human hepegivirus 1 (HHpgV-1), that shares features with hepatitis C virus (HCV) and human pegivirus (HPgV; formerly called GB virus C or hepatitis G virus). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12492por Tien Ng, Kim, Takebe, Yutaka, Bee Chook, Jack, Zhen Chow, Wei, Gan Chan, Kok, Abed Al-Darraji, Haider Abdulrazzaq, Kamarulzaman, Adeeba, Keng Tee, Kok“…Co-infections with human immunodeficiency virus type 1 (HIV-1) and human pegivirus (HPgV) are common in hepatitis C virus (HCV)-infected individuals. However, analysis on the evolutionary dynamics and transmission network profiles of these viruses among individuals with multiple infections remains limited. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12493por Antonello, Vicente Sperb, Antonello, Ivan Carlos Ferreira, Herrmann, Sandra, Tovo, Cristiane Valle“…Characteristics associated with pathological proteinuria after univariate analysis included alcohol abuse, hepatitis C virus coinfection, the occurrence of diabetes and therapy including tenofovir. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12494“…Male and living alone were positive predictors on attendance rate for publicly funded group, and age of first heroin use and hepatitis C virus (HCV) seropositive were negative predictors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12495por Huang, Jean, Ou, Horng-Yih, Lin, James, Karnchanasorn, Rudruidee, Feng, Wei, Samoa, Raynald, Chuang, Lee-Ming, Chiu, Ken C.“…It is well established that liver disease is associated with an increased risk for diabetes mellitus. Hepatitis C virus infection has been known to increase the risk of diabetes. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12496por Huang, He, Hu, Xiao-Feng, Zhao, Fang-Hui, Garland, Suzanne M., Bhatla, Neerja, Qiao, You-Lin“…RESULTS: Across 13 principal Asian countries, the average prevalence and range was 6.6% (0.5% in Japanese women to 15.0% in Vietnamese men) for hepatitis B virus (HBV), 2.6% (0.3% in Iran to 5.1% in Saudi Arabia) for hepatitis C virus (HCV), 7.9% (2.8% in Pakistan to 17.7% in China) for human papillomavirus (HPV), and 61.8% (12.8% in Indonesia to 91.7% in Bangladesh) for Helicobacter pylori (HP). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12497por Hirzel, Cédric, Wandeler, Gilles, Owczarek, Marta, Gorgievski-Hrisoho, Meri, Dufour, Jean-Francois, Semmo, Nasser, Zürcher, Samuel“…METHODS: In a retrospective analysis of 465 HBV samples collected between 2002 and 2013, we evaluated the HBV genotype distribution and phylogenetic determinants, as well as the prevalence of serological evidence of hepatitis delta, hepatitis C and HIV infections in Switzerland. Baseline characteristics of patients were compared across their region of origin using Fisher’s exact test and ANOVA, and risk factors for HBeAg positivity were assessed using logistic regression. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12498por Helliwell, Stephen B., Karkare, Shantanu, Bergdoll, Marc, Rahier, Alain, Leighton-Davis, Juliet R., Fioretto, Celine, Aust, Thomas, Filipuzzi, Ireos, Frederiksen, Mathias, Gounarides, John, Hoepfner, Dominic, Hofmann, Andreas, Imbert, Pierre-Eloi, Jeker, Rolf, Knochenmuss, Richard, Krastel, Philipp, Margerit, Anais, Memmert, Klaus, Miault, Charlotte V., Rao Movva, N., Muller, Alban, Naegeli, Hans-Ulrich, Oberer, Lukas, Prindle, Vivian, Riedl, Ralph, Schuierer, Sven, Sexton, Jessica A., Tao, Jianshi, Wagner, Trixie, Yin, Hong, Zhang, Juan, Roggo, Silvio, Reinker, Stefan, Parker, Christian N.“…Finally, we show that FR171456 inhibits an artificial Hepatitis C viral replicon, and has broad antifungal activity, suggesting potential additional utility as an anti-infective. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12499por Salehi, Maryam, Kalbasi, Nader, Salehi, Hassan, Kassaian, Nazila, Salehi, Marzieh, Khorvash, Farzin, Salehi, Mohamad Mehdi“…All samples were tested for anti-E2 antibodies, hepatitis C virus (HCV)-antibody and hepatitis B virus surface antigen (HBs-Ag) by an enzyme-linked immunosorbent assay and a recombinant immunoblot assay was employed to confirm anti-HCV reactivity. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12500por Wada, Yoshiyuki, Takami, Yuko, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Saitsu, Hideki“…In multivariate analysis, etiology (hepatitis C virus) and initial imaging response (MR+NC) was identified as an independently good prognostic factor. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto